Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | GRM8 | O00222 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9535121 | 0.87 | TDP1 (0.38) | POLBTDP1PKMGRM8GRM2 | |
| SCHEMBL5795999 | 0.87 | TDP1 (0.38) | POLBTDP1PKMGRM8GRM2 | |
| SCHEMBL3782939 | 0.80 | GABRR1 (0.33) | POLBTDP1PKM | |
| SCHEMBL16424387 | 0.78 | PPP5C (0.35) | POLBTDP1PKMGRM2GRM3 | |
| SCHEMBL3779293 | 0.77 | POLB (0.31) | POLBTDP1 | |
| SCHEMBL3787761 | 0.77 | POLB (0.31) | POLBTDP1 | |
| SCHEMBL6321813 | 0.76 | POLB (0.44) | POLBTDP1GRM8GRM2GRM3 | |
| SCHEMBL3779503 | 0.74 | — | — | |
| SCHEMBL17850116 | 0.73 | CYP2C19 (0.38) | — | |
| SCHEMBL19971920 | 0.73 | PPM1B (0.31) | PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795370-B2 | Tetracarboxylic acid compound, polyimide thereof, and production method thereof | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-09-14 | — | — | US | disclosed |
| US-20090182114-A1 | TETRACARBOXYLIC ACID COMPOUND, POLYIMIDE THEREOF, AND PRODUCTION METHOD THEREOF | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182114-A1 | TETRACARBOXYLIC ACID COMPOUND, POLYIMIDE THEREOF, AND PRODUCTION METHOD THEREOF | CA1, TTC14, F12 | POLB 3322/4885TDP1 3178/4885PKM 3120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.